biOasis CEO Purchases Shares

On the back of his recent CEO update to shareholders, in which he expressed great enthusiasm for the Transcend Platform and the opportunity in front of biOasis, Mark Day, Phd, has just filed on a purchase of 33,000 shares of stock bought in the market. We really appreciate this commitment from the new CEO and think it demonstrates his confidence in what the future holds for the Company. We remain very positive on the prospects for biOasis and believe that the shares represent a compelling risk/reward opportunity.